Glucagon-like peptide-1 receptor agonist protects against hyperglycemia-induced cardiocytes injury by inhibiting high mobility group box 1 expression.

Molecular biology reports

Volumn 39, Issue 12, 2012, Pages 10705-10711

  Cai, Yuli ^a   Hu, Xiaorong ^b   Yi, B ^b   Zhang, Ting ^b   Wen, Zhongyuan ^b  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; EXENDIN 4; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; GLUCAGON RECEPTOR; GLUCAGON-LIKE PEPTIDE-1 RECEPTOR; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 1BETA; LACTATE DEHYDROGENASE; MALONALDEHYDE; PEPTIDE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; VENOM;

ANIMAL; ARTICLE; CELL PROTECTION; DRUG EFFECT; DRUG POTENTIATION; ENZYMOLOGY; HEART MUSCLE CELL; HYPERGLYCEMIA; METABOLISM; PATHOLOGY; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; CREATINE KINASE; CYTOPROTECTION; HMGB1 PROTEIN; HYPERGLYCEMIA; INTERLEUKIN-1BETA; L-LACTATE DEHYDROGENASE; MALONDIALDEHYDE; MYOCYTES, CARDIAC; PEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GLUCAGON; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR-ALPHA; VENOMS;

EID: 85027916650     PISSN: None     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-1961-9     Document Type: Article

References (0)